Humacyte secures $1.48M Symvess purchase commitment in Saudi Arabia
Source: SeekingAlpha
2026-03-19 09:04:13 ET
More on Humacyte
- Humacyte, Inc. (HUMA) Presents at Barclays 28th Annual Global Healthcare Conference Transcript
- Humacyte, Inc. (HUMA) Presents at TD Cowen 46th Annual Health Care Conference Transcript
- Humacyte: Positive News For Symvess At Last, But Long-Term Threats Persist
- Humacyte jumps as U.S. legislation backs bioengineered vessels
- Seeking Alpha’s Quant Rating on Humacyte
Read the full article on Seeking Alpha
For further details see:
Humacyte secures $1.48M Symvess purchase commitment in Saudi Arabia
Humacyte Inc. Warrant
NASDAQ: HUMAW
HUMAW Trading
-12.93% G/L:
$0.0505 Last:
960 Volume:
$0.0445 Open:
HUMAW Latest News
HUMAW Stock Data
$247,325,345
156,832,240
N/A
62
N/A
Biotechnology & Life Sciences
Healthcare
US
Durham
